251 related articles for article (PubMed ID: 35726348)
1. Hypothalamic-pituitary-adrenal axis recovery after treatment of Cushing's syndrome.
Balasko A; Zibar Tomsic K; Kastelan D; Dusek T
J Neuroendocrinol; 2022 Aug; 34(8):e13172. PubMed ID: 35726348
[TBL] [Abstract][Full Text] [Related]
2. Extensive clinical experience: Hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess.
Hurtado MD; Cortes T; Natt N; Young WF; Bancos I
Clin Endocrinol (Oxf); 2018 Dec; 89(6):721-733. PubMed ID: 29968420
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome.
He X; Findling JW; Auchus RJ
Pituitary; 2022 Jun; 25(3):393-403. PubMed ID: 35471718
[TBL] [Abstract][Full Text] [Related]
4. The incidence of adrenal crisis in the postoperative period of HPA axis insufficiency after surgical treatment for Cushing's syndrome.
Broersen LHA; van Haalen FM; Kienitz T; Dekkers OM; Strasburger CJ; Pereira AM; Biermasz NR
Eur J Endocrinol; 2019 Aug; 181(2):201-210. PubMed ID: 31167165
[TBL] [Abstract][Full Text] [Related]
5. Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.
Raff H; Sharma ST; Nieman LK
Compr Physiol; 2014 Apr; 4(2):739-69. PubMed ID: 24715566
[TBL] [Abstract][Full Text] [Related]
6. Cushing's syndrome: from physiological principles to diagnosis and clinical care.
Raff H; Carroll T
J Physiol; 2015 Feb; 593(3):493-506. PubMed ID: 25480800
[TBL] [Abstract][Full Text] [Related]
7. Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndrome.
Doherty GM; Nieman LK; Cutler GB; Chrousos GP; Norton JA
Surgery; 1990 Dec; 108(6):1085-90. PubMed ID: 2247834
[TBL] [Abstract][Full Text] [Related]
8. Human studies on hypothalamo-pituitary-adrenal (HPA) axis.
Liyanarachchi K; Ross R; Debono M
Best Pract Res Clin Endocrinol Metab; 2017 Oct; 31(5):459-473. PubMed ID: 29223281
[TBL] [Abstract][Full Text] [Related]
9. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
10. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.
Ceccato F; Barbot M; Zilio M; Ferasin S; Occhi G; Daniele A; Mazzocut S; Iacobone M; Betterle C; Mantero F; Scaroni C
Eur J Endocrinol; 2013 Jul; 169(1):31-6. PubMed ID: 23610124
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of a week one overnight metyrapone test with subsequent dynamic assessments of hypothalamic-pituitary-adrenal axis function after pituitary surgery.
English K; Inder WJ; Weedon Z; Dimeski G; Sorbello J; Russell AW; Duncan EL; Cuneo R
Clin Endocrinol (Oxf); 2017 Jul; 87(1):35-43. PubMed ID: 28329436
[TBL] [Abstract][Full Text] [Related]
12. Cushing's syndrome and adrenocortical insufficiency caused by topical steroids: misuse or abuse?
Güven A; Gülümser O; Ozgen T
J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1173-82. PubMed ID: 18183788
[TBL] [Abstract][Full Text] [Related]
13. The recovery time of hypothalamic-pituitary-adrenal axis after curative surgery in Cushing's disease and its related factor.
Cui Q; Liu X; Sun Q; Sun W; Zheng H; He M; Zhang Z; Ma Z; Shen M; Shou X; Zhao Y; Li Y; Wang Y; Ye H; Zhang S
Endocrine; 2023 Aug; 81(2):349-356. PubMed ID: 37284972
[TBL] [Abstract][Full Text] [Related]
14. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
Khawandanah D; ElAsmar N; Arafah BM
Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid withdrawal syndrome: what to expect and how to manage.
Theiler-Schwetz V; Prete A
Curr Opin Endocrinol Diabetes Obes; 2023 Jun; 30(3):167-174. PubMed ID: 36876715
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
[TBL] [Abstract][Full Text] [Related]
17. PREDICTING RECOVERY OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AFTER PROLONGED GLUCOCORTICOID USE.
Leong SH; Shander S; Ratnasingam J
Endocr Pract; 2018 Jan; 24(1):14-20. PubMed ID: 29368966
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of iatrogenic Cushing syndrome: questions of glucocorticoid withdrawal].
Igaz P; Rácz K; Tóth M; Gláz E; Tulassay Z
Orv Hetil; 2007 Feb; 148(5):195-202. PubMed ID: 17344139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
